Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranjit John

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2007
Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failureRanjit John, Kenneth Liao, Katherine Lietz, et al.
Health Science Reports|May 27, 2022
A retrospective study on the trends in surgical aortic valve replacement outcomes in the post-transcatheter aortic valve replacement eraJohnny Chahine, Zeina Jedeon, Jacob Fiocchi, et al.
Journal of Cardiac Failure|August 26, 2014
HAS-BLED and CHA₂DS₂-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantationRyan J Koene, Sithu Win, Niyada Naksuk, et al.
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2017
A Decade of Experience With Continuous-Flow Left Ventricular Assist DevicesRanjit John, Christopher T Holley, Peter Eckman, et al.
Circulation|March 13, 2002
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipientsSilviu Itescu, Elizabeth Burke, Katherine Lietz, et al.
Human Immunology|March 2, 2002
B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expressionMichael Schuster, Alfred Kocher, Ranjit John, et al.
JACC. Case Reports|June 6, 2025
From Normal to Zero Flow in 30 Seconds on HeartMate 3 LVAD: What Happened?Jessica Schultz, Rebecca Cogswell, Lindsay Berger, et al.
Circulation|October 19, 2005
Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery diseaseKatherine Lietz, Ranjit John, Elizabeth Burke, et al.
The Annals of Thoracic Surgery|August 2, 2017
Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device ImplantationKaustav Majumder, John R Spratt, Christopher T Holley, et al.
Pacing and Clinical Electrophysiology : PACE|January 7, 2011
Long-term mortality and pacing outcomes of patients with permanent pacemaker implantation after cardiac surgerySyed S Raza, Jian-Ming Li, Ranjit John, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Thoracic and Cardiovascular Surgery|July 31, 2007
Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failureRanjit John, Kenneth Liao, Katherine Lietz, et al.
Health Science Reports|May 27, 2022
A retrospective study on the trends in surgical aortic valve replacement outcomes in the post-transcatheter aortic valve replacement eraJohnny Chahine, Zeina Jedeon, Jacob Fiocchi, et al.
Journal of Cardiac Failure|August 26, 2014
HAS-BLED and CHA₂DS₂-VASc scores as predictors of bleeding and thrombotic risk after continuous-flow ventricular assist device implantationRyan J Koene, Sithu Win, Niyada Naksuk, et al.
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2017
A Decade of Experience With Continuous-Flow Left Ventricular Assist DevicesRanjit John, Christopher T Holley, Peter Eckman, et al.
Circulation|March 13, 2002
Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipientsSilviu Itescu, Elizabeth Burke, Katherine Lietz, et al.
Human Immunology|March 2, 2002
B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expressionMichael Schuster, Alfred Kocher, Ranjit John, et al.
JACC. Case Reports|June 6, 2025
From Normal to Zero Flow in 30 Seconds on HeartMate 3 LVAD: What Happened?Jessica Schultz, Rebecca Cogswell, Lindsay Berger, et al.
Circulation|October 19, 2005
Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery diseaseKatherine Lietz, Ranjit John, Elizabeth Burke, et al.
The Annals of Thoracic Surgery|August 2, 2017
Impact of Postoperative Liver Dysfunction on Survival After Left Ventricular Assist Device ImplantationKaustav Majumder, John R Spratt, Christopher T Holley, et al.
Pacing and Clinical Electrophysiology : PACE|January 7, 2011
Long-term mortality and pacing outcomes of patients with permanent pacemaker implantation after cardiac surgerySyed S Raza, Jian-Ming Li, Ranjit John, et al.
Pageof 20